IN-DATE
SARP-30: SJM Seguin Semi-Rigid Annuloplasty Ring 30mm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $249.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Status: | expired |
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in date item only.
Related Items
QUICK VIEW
| SARP-32 - Size: 32.00mm $249.00 per box of 1 SJM Seguin Semi-Rigid Annuloplasty Ring 32mm Expired Units in stock: 1 box of 1 | Order Qty |
|
QUICK VIEW
| SARP-28 - Size: 26.00mm $249.00 per box of 1 SJM Seguin Semi-Rigid Annuloplasty Ring 28mm Expired Units in stock: 1 box of 1 | Order Qty |
|
QUICK VIEW
| SARP-38 - Size: 38.00mm $249.00 per box of 1 SJM Seguin Semi-Rigid Annuloplasty Ring 38mm Expired Units in stock: 1 box of 1 | Order Qty |
|
QUICK VIEW
| SARP-24 - Size: 24.00mm $249.00 per box of 1 SJM Seguin Semi-Rigid Annuloplasty Ring 24mm Expired Units in stock: 1 box of 1 | Order Qty |
|
QUICK VIEW
| SARP-40 - Size: 40.00mm $249.00 per box of 1 SJM Seguin Semi-Rigid Annuloplasty Ring 40mm Expired Units in stock: 2 box of 1 | Order Qty |
Additional Details
Seguin Semi-Rigid Annuloplasty Ring
- Designed to aid cardiac output and left ventricular function
- Semi-rigid, three-dimensional posterior section is designed to preserve the physiologic movement of the valve annulus
- Increased rigidity of the anterior section of the ring promotes annular remodeling
- The solid, one-piece inner core resists needle penetration, reducing the potential for suturing through the core
Manufacturer
Abbott St. Jude Medical has long been a leader in vascular care, through its stents and related products. And, in recent years, the company has built a strong position in mitral valve repair with its MitraClip device. The agreement to acquire St. Jude Medical broadens Abbott's presence in virtually every aspect of cardiovascular care, and will make Abbott one of the world leaders in the broad medical device market.
